CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy

Title
CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy
Authors
Keywords
-
Journal
Cancer Immunology Research
Volume -, Issue -, Pages -
Publisher
American Association for Cancer Research (AACR)
Online
2020-04-08
DOI
10.1158/2326-6066.cir-19-0877

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now